Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors

  1. Steeghs, N.
  2. Gomez-Roca, C.
  3. Rohrberg, K.S.
  4. Mau-Sørensen, M.
  5. Robbrecht, D.
  6. Tabernero, J.
  7. Ahmed, S.
  8. Rodríguez-Ruiz, M.E.
  9. Ardeshir, C.
  10. Schmid, D.
  11. Sleiman, N.
  12. Watson, C.
  13. Piper-Lepoutre, H.
  14. Dejardin, D.
  15. Evers, S.
  16. Boetsch, C.
  17. Charo, J.
  18. Teichgräber, V.
  19. Melero, I.
Journal:
Clinical Cancer Research

ISSN: 1557-3265 1078-0432

Year of publication: 2024

Volume: 30

Issue: 13

Pages: 2693-2701

Type: Article

DOI: 10.1158/1078-0432.CCR-23-3567 GOOGLE SCHOLAR lock_openOpen access editor